Skip to main content
. 2013 Jun 1;8(1):36. doi: 10.1186/2049-6958-8-36

Table 2.

Treatment modalities of COPD patients

 
Group 2 (stage 1 and 2 COPD patients)
Group 3 (stage 3 and 4 COPD patients)
  (n = 20) (n = 20)
Short acting β2 agonist
6
12
Long acting β2 agonist
12
18
Long acting anticholinergic
7
15
Inhaler steroid
6
18
N-acetyl systein
2
7
Long term oxygen therapy
2
10
Pulmoner rehabilitation 0 7